“Strong” = several concordant meta-analyses or systematic reviews. “Moderate” = one synthesis, or several controlled trials. “Limited” = early trials only. The rating is about the quality of the studies, not about how useful the supplement is.
The pregnancy vitamin: before conception, it prevents neural tube defects. Outside of this context, large trials are more mixed.
On cancer, meta-analyses contradict each other: one (10 trials) finds a borderline significant increase in all cancers combined (+7 %) and a significant increase in prostate cancer (+24 %); another, on nearly 50,000 participants from 13 trials followed for an average of 5.2 years, finds no effect, neither overall nor by organ (colon, prostate, lung, breast). Finally, the limitations: in people who already have vascular disease, a meta-analysis on nearly 17,000 participants finds no reduction in cardiovascular disease, stroke, or mortality; the benefit on stroke is concentrated in people with low folate levels. On memory, a meta-analysis of 9 trials (2,835 participants) finds no effect within three years: the positive 3-year trial remains isolated. And the effect on the neural tube assumes starting before pregnancy.
0.4 to 0.8 mg (400 to 800 µg) of folic acid per day for any woman planning or able to start a pregnancy, according to the recommendation of the US Preventive Services Task Force (USPSTF). Start before conception: it is before and at the very beginning of pregnancy that trials measured the effect. Trials on stroke and memory used 0.8 mg per day.
Folic acid supplementation has not been proven effective in reducing the risk of cardiovascular disease or mortality in people with a prior vascular history.
This meta-analysis of 30 randomized clinical trials, involving over 82,000 participants, examined the effect of folic acid supplementation on the risk of cardiovascular disease. The results indicated a 10% reduction in stroke risk and a 4% reduction in the overall risk of cardiovascular disease with folic acid supplementation. Benefits were more pronounced in participants with low plasma folate levels or without pre-existing cardiovascular disease.
Li Y, Huang T, Zheng Y, Muka T, Troup J, Hu FB. — Journal of the American Heart Association (2016) — View the source study
For information only: not a substitute for medical advice. Dietary supplements are not a replacement for a varied, balanced diet. Learn more